Results 101 to 110 of about 5,281 (177)

Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate Lowering Therapy Guidelines for People With CKD. [PDF]

Kidney Int Rep, 2022
Stanley IK, Phoon RKS, Toussaint ND, Cullen V, Kearns J, Dalbeth N, Johnson DW, Krishnasamy R, Tunnicliffe DJ, CARI Guidelines Steering Committee.   +9 more
europepmc   +1 more source

Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial. [PDF]

Arthritis Care Res (Hoboken)
Barry A, England BR, Sayles H, Helget LN, Androsenko M, Wu H, Michaud K, Kramer B, Newcomb JA, Brophy MT, Davis-Karim A, Ferguson R, Pillinger MH, Neogi T, Palevsky PM, O'Dell JR, Mikuls TR.   +16 more
europepmc   +1 more source

I83. Population Use of Urate-Lowering Therapy [PDF]

Rheumatology, 2015
openaire   +1 more source

Gout Remission With Pegloticase-Induced Intensive Urate-Lowering Therapy: A Post Hoc Clinical Trial Analysis. [PDF]

ACR Open Rheumatol
Klionsky Y, Torralba KD, Obermeyer K, Padnick-Silver L, Lam G, LaMoreaux B.   +5 more
europepmc   +1 more source

Outcomes in Patients With Multiple Myeloma and Prescribed Urate-Lowering Therapy: A Propensity-Matched Study. [PDF]

Cureus
Eidbo S, Barnett M, Lema Rodriguez D, Tsibadze N, Pappas A, Shah M, Shah A, Mayo R.   +7 more
europepmc   +1 more source

Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout. [PDF]

BMC Med Inform Decis Mak, 2022
Te Kampe R, Boonen A, Jansen TL, Elling JM, Flendrie M, van Eijk-Hustings Y, Janssen M, van Durme C, de Vries H.   +8 more
europepmc   +1 more source

Combination of sodium-glucose cotransporter type 2 inhibitors and urate-lowering therapy in people with gout from a specialist clinic: a retrospective, single-center observational study. [PDF]

Front Med (Lausanne)
Doménech-Serrano J, García-Loiseau I, Rodríguez-Alvear C, Riesgo-Sanchis P, Moreno-Pérez Ó, Andrés M.   +5 more
europepmc   +1 more source

Pacific community's perceptions on how to improve uptake of urate-lowering therapy for Pacific gout patients. [PDF]

Int J Equity Health
Ofanoa S, Ofanoa M, Tu'akoi S, Lutui H, Heather M, Goodyear-Smith F.   +5 more
europepmc   +1 more source

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout. [PDF]

Int J Med Sci, 2021
Yen FS, Wei JC, Chang CL, Yang CC, Hsu CC, Hwu CM.   +5 more
europepmc   +1 more source

Firsekibart as a Prophylactic Treatment for Acute Gout Flare in Participants Initiating Urate-Lowering Therapy: A Phase 2, Randomized, Open-Label, Multicenter, Active-Controlled Trial. [PDF]

ACR Open Rheumatol
Yu Y, Xue Y, Hu J, Zhang N, Li R, Guo H, Qian L, Gou W, Yang J, Mao L, Yu J, Liu S, Xu Q, Luo T, Zou H.   +14 more
europepmc   +1 more source